Mitchell P. Kopin 13D/13G Filings for Agile Therapeutics, Inc. (AGRX)

Mitchell P. Kopin 13D and 13G filings for Agile Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-06
10:14 am
Sale
2023-12-3113GAGILE THERAPEUTICS INC PAR
AGRX
Mitchell P. Kopin23,961
0.900%
-30,639decrease
(-56.12%)
Filing